DORYX MPC Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Doryx Mpc, and when can generic versions of Doryx Mpc launch?

Doryx Mpc is a drug marketed by Mayne Pharma and is included in one NDA. There are four patents protecting this drug and five Paragraph IV challenges.

This drug has two patent family members in two countries.

The generic ingredient in DORYX MPC is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Doryx Mpc

A generic version of DORYX MPC was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8^th, 1982.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for DORYX MPC?
What are the global sales for DORYX MPC?
What is Average Wholesale Price for DORYX MPC?

Summary for DORYX MPC

International Patents:	2
US Patents:	4
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	55
Patent Applications:	438
Drug Prices:	Drug price information for DORYX MPC
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for DORYX MPC
What excipients (inactive ingredients) are in DORYX MPC?	DORYX MPC excipients list
DailyMed Link:	DORYX MPC at DailyMed

Drug patent expirations by year for DORYX MPC

Pharmacology for DORYX MPC

Drug Class	Tetracycline-class Drug

Paragraph IV (Patent) Challenges for DORYX MPC

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
DORYX MPC	Delayed-release Tablets	doxycycline hyclate	60 mg and 120 mg	050795	1	2017-09-28
DORYX MPC	Delayed-release Tablets	doxycycline hyclate	50 mg	050795	1	2015-11-05
DORYX MPC	Delayed-release Tablets	doxycycline hyclate	80 mg	050795	1	2015-07-01
DORYX MPC	Delayed-release Tablets	doxycycline hyclate	200 mg	050795	1	2014-05-19
DORYX MPC	Delayed-release Tablets	doxycycline hyclate	150 mg	050795	1	2008-12-19

US Patents and Regulatory Information for DORYX MPC

DORYX MPC is protected by four US patents.

Patents protecting DORYX MPC

Tabletting process
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Controlled release doxycycline
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TO TREAT OR PREVENT INFECTIONS CAUSED BY SUSCEPTIBLE BACTERIA USING DELAYED-RELEASE TABLETS CONSISTING OF DOXYCYCLINE HYCLATE COATED PELLETS IN A TABLET

Controlled release doxycycline
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mayne Pharma	DORYX MPC	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	050795-007	May 20, 2016		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Mayne Pharma	DORYX MPC	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	050795-008	May 20, 2016		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Mayne Pharma	DORYX MPC	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	050795-007	May 20, 2016		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for DORYX MPC

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mayne Pharma	DORYX MPC	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	050795-007	May 20, 2016	⤷ Sign Up	⤷ Sign Up
Mayne Pharma	DORYX MPC	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	050795-008	May 20, 2016	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for DORYX MPC

See the table below for patents covering DORYX MPC around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	2006045152		⤷ Sign Up
Australia	2005299253	Improved tabletting process	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration